查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601109

神經血管介入器材市場：按產品、工藝、適應症和最終用途 - 全球預測 2025-2030

Neurovascular Intervention Devices Market by Product (Balloon Systems, Carotid Stents, Catheters), Process (Carotid Endarterectomy, Cerebral Angiography, Coiling), Indication, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

神經血管介入器材市場2023年估值為40.1億美元，預計2024年將達42.5億美元，複合年成長率為6.46%，2030年將達62.1億美元。

神經血管介入設備是用於診斷和治療影響大腦和脊椎血管的神經系統疾病的重要工具。隨著中風和動脈瘤發生率的增加，微創手術需要這些設備來改善患者的治療效果並縮短復原時間。主要應用包括栓塞、血栓切除和支架置入術，為醫院、專科診所和研究機構等最終用戶提供服務。市場成長的關鍵因素是技術進步、世界人口老化和醫療保健成本上升，所有這些都推動了先進治療方法的採用。由於醫療基礎設施投資的增加和患者數量的增加，亞太地區的新興市場提供了龐大的商機。然而，在發展中地區，高成本、法律規範嚴格、熟練專業人員缺乏等因素是限制因素。公司應專注於與醫療提供者的策略夥伴關係關係，並投資於研發，以開發更準確、更安全的下一代、具成本效益的設備。創新機會在於人工智慧和機器人技術的整合，以提高設備性能和患者治療效果，以及先進資料分析促進的個人化患者照護。對生物分解性材料和遠端監控技術的研究也為未來的進步帶來了希望。市場競爭非常激烈，參與企業的和新的參與企業都透過不斷的產品改進和地理擴張來推動創新。為了保持成長，重要的是要掌握技術趨勢、解決成本問題並確保遵守不斷變化的法規。公司必須利用巨量資料和即時監控來提供個人化治療並提高病人參與。正確應對這些挑戰，同時抓住技術進步和新興市場需求，可以幫助企業有效利用神經血管介入器材市場的成長機會。

主要市場統計
基準年[2023] 40.1億美元
預測年份 [2024] 42.5億美元
預測年份 [2030] 62.1億美元
複合年成長率（%） 6.46%

市場動態：揭示快速發展的神經血管介入設備市場的關鍵市場洞察

供需的動態交互作用正在改變神經血管介入器材市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 全球神經血管疾病的發生率不斷上升
    • 微創手術日益偏好青睞
  • 市場限制因素
    • 神經血管介入器材缺乏報銷場景及產品召回
  • 市場機會
    • 神經血管介入器材的技術進展
    • 增加神經血管研發和治療中心的投資
  • 市場問題
    • 神經血管介入器材操作的技術限制

波特五力：駕馭神經血管介入器材市場的策略工具

波特的五力架構是了解神經血管介入器材市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解神經血管介入器材市場的外部影響

外部宏觀環境因素在塑造神經血管介入設備市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解神經血管介入器材市場的競爭格局

對神經血管介入設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：神經血管介入設備市場供應商的績效評估

FPNV 定位矩陣是評估神經血管介入設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

該報告提供了涵蓋關鍵焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球神經血管疾病的發生率增加
      • 人們對微創手術的興趣日益濃厚
    • 抑制因素
      • 神經血管介入器材缺乏報銷方案和產品召回
    • 機會
      • 神經血管介入器材的技術進展
      • 增加神經血管研發和治療中心的投資
    • 任務
      • 神經血管介入裝置操作的技術限制
  • 市場區隔分析
    • 產品：導管在各類血管內神經外科手術的基本作用
    • 流程：擴大神經血管介入器材在腦血管造影術的使用
    • 適應症：用於治療缺血性腦中風的神經血管介入裝置的使用迅速增加
    • 最終用途：醫院引進綜合設備和專業人員 擴大神經血管介入設備
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章神經血管介入設備市場：依產品

  • 介紹
  • 氣球系統
  • 頸動脈支架
  • 導管
  • 栓塞彈簧圈
  • 栓塞防護裝置
  • 分流器
  • 導管導引線
  • 顱內支架
  • 囊內裝置
  • 神經血栓切除裝置
    • 吸引裝置
    • 支架取出裝置
    • 超音波輔助裝置

第7章神經血管介入設備市場：依流程

  • 介紹
  • 頸動脈切除術
  • 腦血管血管造影術
  • 線圈繞製
  • 流量變化
  • 顯微外科夾閉
  • 神經血栓切除術
  • 支架置入

第8章神經血管介入設備市場：依適應症分類

  • 介紹
  • 動靜脈畸形
  • 腦動脈瘤
  • 缺血性中風
  • 狹窄的治療

第9章神經血管介入設備市場：依最終用途分類

  • 介紹
  • 門診手術中心
  • 醫院
  • 專科診所

第10章美洲神經血管介入器材市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太神經血管介入器材市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲神經血管介入器材市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Baylis Medical Technologies 推出 PowerWire Pro 射頻導管導引線以增強靜脈支架再通
    • S3V Vascular Technologies 獲得 30 億印度盧比的 B 輪資金籌措，用於神經血管介入創新，吸引了精英投資者的興趣
    • Nanoflex Robotics 推出用於神經血管介入的創新遠端控制系統
    • Zylox-Tonbridge 與 Avinger 建立策略夥伴關係，推動大中華區神經血管介入創新
    • 飛利浦推出先進的 Azurion Neuro Biplane 介入系統
    • 推出 CEREGLIDE 71，CERENOVUS 的突破性中風干預由 TruCourse 技術提供支持
    • OrbusNeich 和 Abbott 的 CSI 擴大在美國的獨家經銷合作夥伴關係
    • Sensome 和 Asahi Intecc 合作開發先進的人工智慧支援的 Clotild 智慧導絲
    • Stryker 收購 Cerus Endoangio 擴大神經血管介入領域的產品範圍
    • Infinity Neuro 的 Inspira 抽吸導管獲得 CE 標誌

公司名單

  • Abbott Laboratories
  • Acandis GmbH
  • Asahi Intecc Co., Ltd.
  • Balt Group
  • Boston Scientific Corporation
  • Carl Zeiss AG
  • Edwards Lifesciences Corporation
  • Evasc Medical Systems Corp.
  • GE Healthcare
  • Imperative Care Inc.
  • Integer Holdings Corporation
  • Japan Lifeline Co.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medikit Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Microport Scientific Corporation
  • Nanoflex Robotics AG
  • NeuroSafe Medical Co., Ltd.
  • Penumbra, Inc.
  • Phenox GmbH by Wallaby Medical, LLC
  • Rapid Medical Ltd.
  • Route 92 Medical, Inc.
  • Siemens Healthineers AG
  • Stryker Corporation
  • Terumo Corporation
  • Zylox-Tonbridge Medical Technology Co., Ltd.
Product Code: MRR-ED54C46E8FA1

The Neurovascular Intervention Devices Market was valued at USD 4.01 billion in 2023, expected to reach USD 4.25 billion in 2024, and is projected to grow at a CAGR of 6.46%, to USD 6.21 billion by 2030.

Neurovascular intervention devices are critical tools used in the diagnosis and treatment of neurological disorders affecting blood vessels in the brain and spine. As the prevalence of strokes and aneurysms rises, these devices have become necessary for minimally invasive procedures that enhance patient outcomes and reduce recovery times. The primary applications include embolization, thrombectomy, and stenting, serving end-users like hospitals, specialized clinics, and research institutions. Market growth is chiefly influenced by technological advancements, an aging global population, and rising health expenditures, all of which encourage the adoption of advanced treatment methods. Emerging markets in Asia-Pacific offer substantial opportunities due to increasing investments in healthcare infrastructure and a growing patient pool. However, factors like the high cost of devices, stringent regulatory frameworks, and a lack of skilled professionals in developing regions pose limitations. Companies should focus on strategic partnerships with healthcare providers and invest in R&D to develop cost-effective, next-generation devices with enhanced precision and safety features. Innovation opportunities lie in the integration of AI and robotics for improved device performance and patient outcomes, along with personalized patient care facilitated by advanced data analytics. Research on biodegradable materials and remote monitoring technologies also holds promise for future advancements. The market is competitive, with both established players and new entrants driving innovation through continuous product enhancements and geographical expansion. Staying attuned to technological trends, addressing cost concerns, and ensuring compliance with evolving regulations are crucial for sustaining growth. Companies should leverage big data and real-time monitoring to provide personalized therapies and improve patient engagement. Adequately addressing these challenges while seizing technological advancements and emerging market demand will position businesses to capitalize on growth opportunities in the neurovascular intervention devices market effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 4.01 billion
Estimated Year [2024] USD 4.25 billion
Forecast Year [2030] USD 6.21 billion
CAGR (%) 6.46%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Intervention Devices Market

The Neurovascular Intervention Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of neurovascular diseases worldwide
    • Growing preference for minimally invasive procedures
  • Market Restraints
    • Lack of reimbursement scenario and product recall for neurovascular intervention devices
  • Market Opportunities
    • Technological advancements in neurovascular intervention devices
    • Rising investments in neurovascular R&D and treatment center
  • Market Challenges
    • Technical limitations of operating neurovascular intervention devices

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Intervention Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Intervention Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Intervention Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Intervention Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Intervention Devices Market

A detailed market share analysis in the Neurovascular Intervention Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Intervention Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Intervention Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Intervention Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Asahi Intecc Co., Ltd., Balt Group, Boston Scientific Corporation, Carl Zeiss AG, Edwards Lifesciences Corporation, Evasc Medical Systems Corp., GE Healthcare, Imperative Care Inc., Integer Holdings Corporation, Japan Lifeline Co., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., LivaNova PLC, Medikit Co., Ltd., Medtronic PLC, Merit Medical Systems, Inc., Microport Scientific Corporation, Nanoflex Robotics AG, NeuroSafe Medical Co., Ltd., Penumbra, Inc., Phenox GmbH by Wallaby Medical, LLC, Rapid Medical Ltd., Route 92 Medical, Inc., Siemens Healthineers AG, Stryker Corporation, Terumo Corporation, and Zylox-Tonbridge Medical Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Intervention Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Balloon Systems, Carotid Stents, Catheters, Embolic Coils, Embolic Protection Devices, Flow Diverters, Guidewires, Intracranial Stents, Intrasaccular Devices, and Neurothrombectomy Devices. The Neurothrombectomy Devices is further studied across Aspiration Devices, Stent Retrievers, and Ultrasound-assisted Devices.
  • Based on Process, market is studied across Carotid Endarterectomy, Cerebral Angiography, Coiling, Flow Diversion, Microsurgical Clipping, Neurothrombectomy, and Stenting.
  • Based on Indication, market is studied across Arteriovenous Malformations, Cerebral Aneurysms, Ischemic Strokes, and Stenosis Treatment.
  • Based on End-use, market is studied across Ambulatory Surgical Centers, Hospitals, and Speciality Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of neurovascular diseases worldwide
      • 5.1.1.2. Growing preference for minimally invasive procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of reimbursement scenario and product recall for neurovascular intervention devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in neurovascular intervention devices
      • 5.1.3.2. Rising investments in neurovascular R&D and treatment center
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of operating neurovascular intervention devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Fundamental role of catheters in various types of endovascular neurosurgical procedures
    • 5.2.2. Process: Proliferating utilization of neurovascular intervention devices in cerebral angiography
    • 5.2.3. Indication: Burgeoning utilization of neurovascular intervention devices for ischemic strokes
    • 5.2.4. End-use: Comprehensive facilities and specialized personnel in hospitals expanding the adoption of neurovascular intervention devices
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurovascular Intervention Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Balloon Systems
  • 6.3. Carotid Stents
  • 6.4. Catheters
  • 6.5. Embolic Coils
  • 6.6. Embolic Protection Devices
  • 6.7. Flow Diverters
  • 6.8. Guidewires
  • 6.9. Intracranial Stents
  • 6.10. Intrasaccular Devices
  • 6.11. Neurothrombectomy Devices
    • 6.11.1. Aspiration Devices
    • 6.11.2. Stent Retrievers
    • 6.11.3. Ultrasound-assisted Devices

7. Neurovascular Intervention Devices Market, by Process

  • 7.1. Introduction
  • 7.2. Carotid Endarterectomy
  • 7.3. Cerebral Angiography
  • 7.4. Coiling
  • 7.5. Flow Diversion
  • 7.6. Microsurgical Clipping
  • 7.7. Neurothrombectomy
  • 7.8. Stenting

8. Neurovascular Intervention Devices Market, by Indication

  • 8.1. Introduction
  • 8.2. Arteriovenous Malformations
  • 8.3. Cerebral Aneurysms
  • 8.4. Ischemic Strokes
  • 8.5. Stenosis Treatment

9. Neurovascular Intervention Devices Market, by End-use

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Speciality Clinics

10. Americas Neurovascular Intervention Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Neurovascular Intervention Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Neurovascular Intervention Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Baylis Medical Technologies Introduces PowerWire Pro RF Guidewire for Enhanced Venous Stent Recanalization
    • 13.3.2. S3V Vascular Technologies Secures Key Series B Funding of INR 300 Crore for Neurovascular Intervention Innovation, Attracting Elite Investor Interest
    • 13.3.3. Nanoflex Robotics Deployed Revolutionary Remote-Operable System for Neurovascular Interventions
    • 13.3.4. Zylox-Tonbridge Forms Strategic Alliance with Avinger to Innovate Neurovascular Interventions in Greater China
    • 13.3.5. Philips Unveils Advanced Azurion Neuro Biplane Interventional System
    • 13.3.6. Introducing CEREGLIDE 71 a CERENOVUS's Breakthrough in Stroke Intervention with TruCourse Technology
    • 13.3.7. OrbusNeich and Abbott's CSI Extend Exclusive Distribution Partnership in the U.S. through 2027
    • 13.3.8. Sensome and Asahi Intecc Collaborate on Advanced AI-Powered Clotild Smart Guidewire
    • 13.3.9. Stryker's Acquired Cerus Endovascular to Expand its Offering in the Neurovascular Intervention Sector
    • 13.3.10. Infinity Neuro Secures CE Mark for Inspira Aspiration Catheters

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acandis GmbH
  • 3. Asahi Intecc Co., Ltd.
  • 4. Balt Group
  • 5. Boston Scientific Corporation
  • 6. Carl Zeiss AG
  • 7. Edwards Lifesciences Corporation
  • 8. Evasc Medical Systems Corp.
  • 9. GE Healthcare
  • 10. Imperative Care Inc.
  • 11. Integer Holdings Corporation
  • 12. Japan Lifeline Co.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Koninklijke Philips N.V.
  • 15. Lepu Medical Technology (Beijing) Co., Ltd.
  • 16. LivaNova PLC
  • 17. Medikit Co., Ltd.
  • 18. Medtronic PLC
  • 19. Merit Medical Systems, Inc.
  • 20. Microport Scientific Corporation
  • 21. Nanoflex Robotics AG
  • 22. NeuroSafe Medical Co., Ltd.
  • 23. Penumbra, Inc.
  • 24. Phenox GmbH by Wallaby Medical, LLC
  • 25. Rapid Medical Ltd.
  • 26. Route 92 Medical, Inc.
  • 27. Siemens Healthineers AG
  • 28. Stryker Corporation
  • 29. Terumo Corporation
  • 30. Zylox-Tonbridge Medical Technology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR INTERVENTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR INTERVENTION DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY BALLOON SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC COILS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INTRASACCULAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ASPIRATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ULTRASOUND-ASSISTED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CAROTID ENDARTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANGIOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COILING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY FLOW DIVERSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY MICROSURGICAL CLIPPING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY ISCHEMIC STROKES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STENOSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY SPECIALITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 125. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 130. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. THAILAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 135. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. VIETNAM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 146. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. DENMARK NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 150. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 151. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EGYPT NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 156. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. FINLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 161. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. FRANCE NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 166. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. GERMANY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 171. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. ISRAEL NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 176. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. ITALY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 180. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 181. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NETHERLANDS NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 185. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 186. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. NIGERIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 191. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. NORWAY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 196. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. POLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 200. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 201. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. QATAR NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 205. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 206. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. RUSSIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 210. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 211. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SAUDI ARABIA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH AFRICA NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 221. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SPAIN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 226. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. SWEDEN NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 231. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SWITZERLAND NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 235. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 236. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. TURKEY NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED ARAB EMIRATES NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY NEUROTHROMBECTOMY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 246. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 247. UNITED KINGDOM NEUROVASCULAR INTERVENTION DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 248. NEUROVASCULAR INTERVENTION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 249. NEUROVASCULAR INTERVENTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023